Could a weight-loss drug improve blood sugar control in type 1 diabetes?
NCT ID NCT06820281
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 31 times
Summary
This study tests whether tirzepatide, a drug used for type 2 diabetes and weight loss, can help people with type 1 diabetes. 44 adults with type 1 diabetes and a BMI of 27 or higher will receive either tirzepatide or a placebo for 6 weeks. Researchers will measure how the drug affects insulin sensitivity, hormone levels after meals, and responses to low blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Garvan Institute of Medical Research
Sydney, New South Wales, 2010, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.